Sailong Pharmaceutical Group Co.,Ltd. (SHE:002898)

China flag China · Delayed Price · Currency is CNY
11.45
+0.55 (5.05%)
Mar 10, 2026, 3:04 PM CST
10.31%
Market Cap 1.92B
Revenue (ttm) 244.84M
Net Income (ttm) -69.85M
Shares Out 176.00M
EPS (ttm) -0.40
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,356,510
Average Volume 2,016,425
Open 11.00
Previous Close 10.90
Day's Range 10.91 - 11.45
52-Week Range 5.77 - 17.49
Beta 0.25
RSI 33.78
Earnings Date Apr 27, 2026

About SHE:002898

Sailong Pharmaceutical Group Co.,Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China. The company offers esomeprazole sodium, ornithine aspartate, thymus, argatroban, tigecycline, monosialotetrahexose ganglioside sodium, cerebroprotein hydrolysate, milrinone, parecoxib sodium, tranexamic acid, clindamycin phosphate, pantoprazole sodium products, etc. It provides its products for therapeutic areas, such as cardiovascular, cerebrovascular, nerve, digestive system, proto... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 514
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002898
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.